Reinforcing effects of opioid/cannabinoid mixtures in rhesus monkeys responding under a food/drug choice procedure

[1]  K. Humphreys,et al.  It is premature to expand access to medicinal cannabis in hopes of solving the US opioid crisis. , 2018, Addiction.

[2]  A. Abraham,et al.  Association Between US State Medical Cannabis Laws and Opioid Prescribing in the Medicare Part D Population , 2018, JAMA internal medicine.

[3]  J. Hockenberry,et al.  Association of Medical and Adult-Use Marijuana Laws With Opioid Prescribing for Medicaid Enrollees , 2018, JAMA internal medicine.

[4]  G. Bedi,et al.  Impact of co-administration of oxycodone and smoked cannabis on analgesia and abuse liability , 2018, Neuropsychopharmacology.

[5]  R. Lamb,et al.  Addiction as a BAD, a Behavioral Allocation Disorder , 2018, Pharmacology Biochemistry and Behavior.

[6]  K. Freeman,et al.  Pharmacotherapies for decreasing maladaptive choice in drug addiction: Targeting the behavior and the drug , 2018, Pharmacology Biochemistry and Behavior.

[7]  B. Betz-Stablein,et al.  Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis , 2017, Neuropsychopharmacology.

[8]  M. Banks,et al.  Insights from Preclinical Choice Models on Treating Drug Addiction. , 2017, Trends in pharmacological sciences.

[9]  C. France,et al.  Interactions between cannabinoid receptor agonists and mu opioid receptor agonists in rhesus monkeys discriminating fentanyl. , 2016, European journal of pharmacology.

[10]  D. Clauw,et al.  Medical Cannabis Use Is Associated With Decreased Opiate Medication Use in a Retrospective Cross-Sectional Survey of Patients With Chronic Pain. , 2016, The journal of pain : official journal of the American Pain Society.

[11]  R. Lamb,et al.  Determinants of choice, and vulnerability and recovery in addiction , 2016, Behavioural Processes.

[12]  C. France,et al.  Delay discounting of the &mgr;-opioid receptor agonist remifentanil in rhesus monkeys , 2016, Behavioural pharmacology.

[13]  C. France,et al.  Effects of daily delta-9-tetrahydrocannabinol treatment on heroin self-administration in rhesus monkeys , 2016, Behavioural pharmacology.

[14]  Roger Chou,et al.  CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016. , 2016, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[15]  R. Chou,et al.  CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016. , 2016, JAMA.

[16]  C. France,et al.  Impact of Efficacy at the μ-Opioid Receptor on Antinociceptive Effects of Combinations of μ-Opioid Receptor Agonists and Cannabinoid Receptor Agonists , 2014, The Journal of Pharmacology and Experimental Therapeutics.

[17]  C. Cunningham,et al.  Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010. , 2014, JAMA internal medicine.

[18]  Marie J. Hayes,et al.  Legalization of medical marijuana and incidence of opioid mortality. , 2014, JAMA internal medicine.

[19]  L. Hrubá,et al.  The cannabinoid agonist HU-210: pseudo-irreversible discriminative stimulus effects in rhesus monkeys. , 2014, European journal of pharmacology.

[20]  Carla H. Lagorio,et al.  Random-ratio schedules produce greater demand for i.v. drug administration than fixed-ratio schedules in rhesus monkeys , 2014, Psychopharmacology.

[21]  C. France,et al.  Effect of Delay on Self-Administration of Remifentanil under a Drug Versus Drug Choice Procedure in Rhesus Monkeys , 2013, The Journal of Pharmacology and Experimental Therapeutics.

[22]  C. France,et al.  Interactions between μ-Opioid Receptor Agonists and Cannabinoid Receptor Agonists in Rhesus Monkeys: Antinociception, Drug Discrimination, and Drug Self-Administration , 2013, The Journal of Pharmacology and Experimental Therapeutics.

[23]  C. France,et al.  Delay discounting of food and remifentanil in rhesus monkeys , 2013, Psychopharmacology.

[24]  W. Koek,et al.  Interactions between &Dgr;9-tetrahydrocannabinol and heroin: self-administration in rhesus monkeys , 2012, Behavioural pharmacology.

[25]  Mikhail N Koffarnus,et al.  Individual differences in rhesus monkeys' demand for drugs of abuse , 2012, Addiction biology.

[26]  Udo Albus,et al.  Book Review: Guide for the Care and use of Laboratory Animals , 1998 .

[27]  K. Freeman,et al.  Self-administration of cocaine and remifentanil by monkeys: choice between single drugs and mixtures , 2011, Psychopharmacology.

[28]  A. Riley.  The paradox of drug taking: The role of the aversive effects of drugs , 2011, Physiology & Behavior.

[29]  L. McMahon.  Chronic Δ9‐tetrahydrocannabinol treatment in rhesus monkeys: differential tolerance and cross‐tolerance among cannabinoids , 2011, British journal of pharmacology.

[30]  P. Piazza,et al.  Bimodal control of stimulated food intake by the endocannabinoid system , 2010, Nature Neuroscience.

[31]  C. France,et al.  Interactions between Δ9-tetrahydrocannabinol and μ opioid receptor agonists in rhesus monkeys: discrimination and antinociception , 2008, Psychopharmacology.

[32]  R. Tallarida,et al.  Self-administration of cocaine–remifentanil mixtures by monkeys: an isobolographic analysis , 2008, Psychopharmacology.

[33]  Mikhail N. Koffarnus,et al.  Quantification of drug choice with the generalized matching law in rhesus monkeys. , 2008, Journal of the experimental analysis of behavior.

[34]  J. Woods,et al.  A behavioral economic analysis of cocaine and remifentanil self-administration in rhesus monkeys , 2007, Psychopharmacology.

[35]  L. McMahon.  Characterization of Cannabinoid Agonists and Apparent pA2 Analysis of Cannabinoid Antagonists in Rhesus Monkeys Discriminating Δ9-Tetrahydrocannabinol , 2006, Journal of Pharmacology and Experimental Therapeutics.

[36]  S R Hursh,et al.  Relative Reinforcing Effects of Cocaine, Remifentanil, and Their Combination in Rhesus Monkeys , 2006, Journal of Pharmacology and Experimental Therapeutics.

[37]  S. Negus.  Choice between Heroin and Food in Nondependent and Heroin-Dependent Rhesus Monkeys: Effects of Naloxone, Buprenorphine, and Methadone , 2006, Journal of Pharmacology and Experimental Therapeutics.

[38]  K. Rice,et al.  Interactions between δ and μ Opioid Agonists in Assays of Schedule-Controlled Responding, Thermal Nociception, Drug Self-Administration, and Drug versus Food Choice in Rhesus Monkeys: Studies with SNC80 [(+)-4-[(αR)-α-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide , 2005, Journal of Pharmacology and Experimental Therapeutics.

[39]  S. Negus.  Effects of punishment on choice between cocaine and food in rhesus monkeys , 2005, Psychopharmacology.

[40]  S. Negus.  Interactions between the reinforcing effects of cocaine and heroin in a drug-vs-food choice procedure in rhesus monkeys: a dose-addition analysis , 2005, Psychopharmacology.

[41]  J. Woods,et al.  Observing responses maintained by stimuli associated with cocaine or remifentanil reinforcement in rhesus monkeys , 2002, Psychopharmacology.

[42]  S. Hursh,et al.  Relative reinforcing effects of three opioids with different durations of action. , 2002, The Journal of pharmacology and experimental therapeutics.

[43]  T. Kirkham,et al.  Endogenous cannabinoids and appetite , 2001, Nutrition Research Reviews.

[44]  I. McGregor,et al.  Aversive effects of the synthetic cannabinoid CP 55,940 in rats , 1996, Pharmacology Biochemistry and Behavior.

[45]  Division on Earth.  Guide for the Care and Use of Laboratory Animals , 1996 .

[46]  M. Nader,et al.  Choice between cocaine and food by rhesus monkeys: effects of conditions of food availability. , 1992, Behavioural pharmacology.

[47]  L. Hollister,et al.  Plasma delta‐9‐tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking , 1980, Clinical pharmacology and therapeutics.

[48]  E. Abel.  Cannabis: effects on hunger and thirst. , 1975, Behavioral biology.

[49]  T F Elsmore,et al.  Δ9-Tetrahydrocannabinol: Aversive Effects in Rat at High Doses , 1972, Science.

[50]  W. Koek,et al.  Interactions between delta 9-tetrahydrocannabinol and heroin : self-administration in rhesus monkeys , 2015 .

[51]  C. Galuska,et al.  Effects of daily morphine administration and deprivation on choice and demand for remifentanil and cocaine in rhesus monkeys. , 2011, Journal of the experimental analysis of behavior.

[52]  Christopher A. Podlesnik,et al.  The effects of nociceptin/orphanin FQ receptor agonist Ro 64-6198 and diazepam on antinociception and remifentanil self-administration in rhesus monkeys , 2010, Psychopharmacology.

[53]  M. Nader,et al.  Effects of increasing the magnitude of an alternative reinforcer on drug choice in a discrete-trials choice procedure , 2005, Psychopharmacology.

[54]  Franjo Grotenhermen,et al.  Pharmacokinetics and Pharmacodynamics of Cannabinoids , 2003, Clinical pharmacokinetics.